New study: curcumin may lead to prolonged survival and delay in progressive disease of some MGUS, SMM, and CLL patients

Hot off the press: http://goo.gl/F0whJs Here’s what the abstract tells us:

“Clinical studies with patients with early hematological malignancies (ie, monoclonal gammopathy of undetermined significance, smoldering multiple myeloma, or stage 0/1 chronic lymphocytic leukemia) suggest that early intervention with curcumin, derived from the spice turmeric, may lead to prolonged survival and delay in progressive disease in some of these patients.” 

I’m curious to see the full study…But it hasn’t been published yet…Still, this is a rather nice Christmas present, don’t you think? :-)